癌症诊断市场规模、份额、成长分析（按产品、技术、应用、最终用户、地区）- 2025 年至 2032 年产业预测

2023 年癌症诊断市场规模价值 1,100 亿美元，预计将从 2024 年的 1,196.8 亿美元成长到 2032 年的 2,349.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.8%。

由于全球癌症病例不断增加，预计未来几年对癌症诊断药物的需求将大幅增加。市场成长的关键驱动力包括对肿瘤学研究的大量投资以及对癌症早期发现的日益关注，从而改善治疗效果。此外，人们对各种癌症类型的认识不断提高以及诊断技术的创新预计将进一步推动需求。此外，向标靶治疗和个人化医疗的转变也将推动先进诊断工具的使用。然而，高成本、误报风险和访问受限等挑战可能会限制这段时期及以后的市场潜力。总体而言，癌症诊断市场预计将在这些不断变化的动态中经历显着成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 专利分析
• 监管分析
• 技术分析
• 案例研究

癌症诊断市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 耗材
  • 抗体
  • 套件和试剂
  • 探测
  • 其他耗材
• 装置
  • 基于病理学的仪器
  • 玻片染色系统
  • 组织处理系统
  • 细胞处理器
  • PCR设备
  • NGS设备
  • 微阵列
  • 其他基于病理学的仪器
  • 影像设备
  • CT系统
  • 超音波系统
  • MRI系统
  • 乳房X光摄影系统
  • 核子造影系统
  • 切片检查器械

癌症诊断市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 体外诊断测试
  • 聚合酵素链锁反应
  • 原位杂交
  • 免疫组织化学
  • 次世代定序
  • 免疫检测
  • 微阵列
  • 流式细胞技术
  • 其他 IVD 技术
• 影像技术
  • 磁振造影
  • 电脑断层扫描
  • 核子造影
  • 乳房X光检查
  • 超音波
• 切片检查

癌症诊断市场规模（按应用）及复合年增长率（2025-2032）

• 市场概览
• 乳癌
• 肺癌
• 大肠直肠癌
• 黑色素瘤
• 其他癌症

癌症诊断市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 诊断实验室

癌症诊断市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（US）
• Becton, Dickinson and Company（BD）（US）
• bioMerieux SA（France）
• Danaher Corporation（US）
• Hoffmann-La Roche Ltd.（Switzerland）
• GE Healthcare（US）
• Hologic, Inc.（US）
• Illumina, Inc.（US）
• Koninklijke Philips NV（Netherlands）
• Merck KGaA（Germany）
• Myriad Genetics, Inc.（US）
• QIAGEN NV（Netherlands）
• Siemens Healthineers AG（Germany）
• Sysmex Corporation（Japan）
• Thermo Fisher Scientific Inc.（US）
• Exact Sciences Corporation（US）
• Guardant Health, Inc.（US）
• Caris Life Sciences（US）

结论和建议

Cancer Diagnostics Market size was valued at USD 110.0 billion in 2023 and is poised to grow from USD 119.68 billion in 2024 to USD 234.99 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global rise in cancer incidences is set to significantly enhance the demand for cancer diagnostics in the coming years. Key drivers for market growth include substantial investments in oncology research and an increasing focus on early cancer detection, which can lead to improved treatment outcomes. Additionally, heightened awareness of various cancer types and innovations in diagnostic technologies are expected to further boost demand. The shift towards targeted therapies and personalized medicine will also propel the use of advanced diagnostic tools. However, challenges such as high costs, the risk of false positives, and restricted access may limit market potential throughout this period and beyond. Overall, the cancer diagnostics market is poised for substantial growth amidst these evolving dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cancer Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cancer Diagnostics Market Segments Analysis

Global Cancer Diagnostics Market is segmented by Product, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into IVD Testing, Imaging Technologies and Biopsies. Based on Application, the market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma and Other Cancers. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cancer Diagnostics Market

The rising prevalence of cancer has become a pressing issue globally, largely driven by poor lifestyle choices and the widespread adoption of unhealthy habits. This increase in cancer incidence is a major catalyst for the growing demand for cancer diagnostics. As more individuals are diagnosed with various types of cancer, there is an urgent need for effective diagnostic tools and services to support early detection and treatment. Consequently, the cancer diagnostics market is experiencing significant growth, addressing the critical need for timely and accurate diagnosis, thus ultimately improving patient outcomes and advancing healthcare solutions in this vital area.

Restraints in the Cancer Diagnostics Market

The Cancer Diagnostics market faces significant restraints, particularly in underdeveloped and developing nations that are still striving to enhance their healthcare infrastructure. In these regions, healthcare facilities often operate with constrained budgets, limiting their ability to invest in advanced diagnostic technologies. As a result, access to innovative diagnostic procedures is significantly hampered, hindering the identification and treatment of cancer. This lack of financial resources restricts the adoption of state-of-the-art diagnostic devices, ultimately impacting the overall effectiveness and progression of cancer diagnosis in these markets. Consequently, this limitation poses a notable challenge to the growth of the Cancer Diagnostics industry globally.

Market Trends of the Cancer Diagnostics Market

The Cancer Diagnostics market is witnessing a significant trend toward the integration of artificial intelligence (AI) technologies, poised to revolutionize traditional diagnostic methods. Companies are increasingly leveraging AI in diagnostic imaging, enhancing accuracy and efficiency in identifying malignancies at earlier stages. This innovation not only streamlines the diagnostic process but also presents new business opportunities for companies specializing in cancer detection. By harnessing the power of AI, firms can improve patient outcomes, reduce diagnostic errors, and optimize resource allocation. As the demand for precise and rapid cancer diagnostics grows, the successful adoption of AI will be a critical differentiator in a competitive landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Cancer Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
  • Antibodies
  • Kits & Reagents
  • Probes
  • Other Consumables
• Instruments
  • Pathology-Based Instruments
  • Slide staining systems
  • Tissue processing systems
  • Cell processors
  • PCR instruments
  • NGS instruments
  • Microarrays
  • Other pathology-based instruments
  • Imaging Instruments
  • CT systems
  • Ultrasound systems
  • MRI systems
  • Mammography systems
  • Nuclear imaging systems
  • Biopsy Instruments

Global Cancer Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• IVD Testing
  • Polymerase Chain Reaction
  • In Situ Hybridization
  • Immunohistochemistry
  • Next-Generation Sequencing
  • Immunoassay
  • Microarray
  • Flow Cytometry
  • Other IVD Technologies
• Imaging Technologies
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Nuclear Imaging
  • Mammography
  • Ultrasound
• Biopsies

Global Cancer Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Other Cancers

Global Cancer Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories

Global Cancer Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caris Life Sciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations